Introduction
============

Short-chain fatty acids (SCFAs, also known as volatile fatty acids or VFAs) are produced in the gastrointestinal tract by microbial fermentation of carbohydrate substrates of both exogenous (dietary fiber) and endogenous origin (mucus). SCFAs contribute up to 75% of the total energy requirement in ruminants and \~10% for humans.[@b1-grsb-6-2012-067] A broad range of biological functions have been ascribed to SCFAs, specifically butyrate, in addition to their value in energy and nutrition metabolism.[@b1-grsb-6-2012-067],[@b2-grsb-6-2012-067] While as a preferred energy source for ruminal epithelial cells, butyrate plays a critical role in the development of the rumen epithelium.[@b3-grsb-6-2012-067] As an indirect factor, butyrate is able to affect blood flow in the gastrointestinal (GI) tract as well as insulin and glucagon secretion.[@b1-grsb-6-2012-067] Furthermore, butyrate reinforces intestinal barriers and modulates motility and visceral sensitivity of the intestine.[@b4-grsb-6-2012-067] Butyrate modulates cell differentiation and motility, induces apoptosis, and inhibits cell proliferation in vitro[@b5-grsb-6-2012-067],[@b6-grsb-6-2012-067] in contrast to the observed effects on cell proliferation documented in vivo[@b7-grsb-6-2012-067] Butyrate is known to be anti-inflammatory and anti-tumorigenic.[@b4-grsb-6-2012-067] Recently, butyrate has been shown to reduce bacterial translocation and internalization resulting from metabolic stress in human colon-derived cells.[@b8-grsb-6-2012-067] Beneficial effects of butyrate on human health and animal well-being have been extensively reviewed.[@b4-grsb-6-2012-067],[@b9-grsb-6-2012-067]

Steady-state butyrate concentration in the rumen represents a balance between butyrate biosynthesis by ruminal microorganisms and absorption and utilization by the rumen epithelium. Among factors that affect butyrate output of the gut microbial ecosystem, such as redox potential and pH, gut turnover and motility, and mucosal transport,[@b10-grsb-6-2012-067] substrates in the gut play an essential role in butyrate production, possibly due to their influence on microbial population composition and dynamics.[@b10-grsb-6-2012-067]--[@b12-grsb-6-2012-067] The community-level response of rumen microorganisms to exogenous butyrate has recently been characterized.[@b12-grsb-6-2012-067] Dietary supplements, such as butyrogenic resistant starch, and probiotic administration of butyrate-producing bacteria have been exploited in human medicine to boost gut butyrate concentration for its potential health benefit.[@b13-grsb-6-2012-067]--[@b15-grsb-6-2012-067] In ruminants, butyrate produced by gut microbes is rapidly removed by the rumen or gut epithelium, and subsequently metabolized to ketone bodies (acetoacetate and β-hydroxybutyrate) or oxidized to CO~2~ prior to being released into circulation such that only 25% of the butyrate enters the systemic circulation.[@b16-grsb-6-2012-067] While substantial amounts of butyrate are absorbed across the rumen epithelium via passive diffusion, either trans- or para-cellularly,[@b17-grsb-6-2012-067] other forms of butyrate transport may exist. Indeed, a butyrate transporter, SLC5A8, has been identified.[@b18-grsb-6-2012-067] Much of our knowledge relating to the transcriptional effects of butyrate is derived from in vitro studies.[@b2-grsb-6-2012-067] However, butyrate has long been known to have an opposite effect in vivo, especially on cell proliferation. In the present study, we quantified the changes in the rumen epithelial transcriptome of dairy cows in response to butyrate infusion using RNA-seq technology and bioinformatic tools.

Materials and Methods
=====================

Animal experiment
-----------------

Four ruminally-cannulated Holstein cows used in this study were previously described.[@b12-grsb-6-2012-067] Briefly, the cows in their mid-lactation were fed *ad libitum* standard lactation rations with 50% corn silage and 50% concentrate on a dry matter basis. All animal care and handling were conducted according to the guidelines approved by the USDA Beltsville Area Institutional Animal Care (Protocol \# 09-008). Cows were moved to a tie stall barn for adaptation and acclimation 7 days prior to the experiment. Ruminal infusion of butyrate was initiated immediately following 0h sampling (baseline controls) and thereafter continued for 168 h at a rate of 5.0 L/day of a 2.5 M solution (representing \>10% of daily anticipated metabolizable energy intake to support lactation) in a buffered saliva solution (pH 7.0; 3.8% KHCO~3~, 7.3% NaHCO~3~) as a continuous infusion. Following the 168 h infusion, infusion was stopped and cows were maintained on the basal lactation ration for an additional 168 h for sampling. Rumen epithelial samples were serially collected via biopsy through rumen fistulae at 0, 24, 72, and 168 h of infusion, and 24 and 168 h post infusion (post 24 h and post 168 h, respectively). Ruminal pH was monitored using a standard pH meter and recorded at every sampling. Rumen epithelial samples were saved in RNAlater and stored in −80C until RNA extraction. Additionally, a bovine epithelial cell line treated with 10 mM of sodium butyrate (*N* = 4) and PBS, respectively, for 24 h was used as an in vitro model for comparison.[@b2-grsb-6-2012-067]

RNA extraction and sequencing using RNA-seq
-------------------------------------------

Total RNA from 24 rumen epithelial samples and 8 cell line samples was extracted using Trizol (Invitrogen, Carlsbad, CA, USA) followed by DNase digestion and Qiagen RNeasy column purification (Qiagen, Valencia, CA, USA) as previously described.[@b19-grsb-6-2012-067],[@b20-grsb-6-2012-067] The RNA integrity was verified using an Agilent Bioanalyzer 2100 (Agilent, Palo Alto, CA, USA). High-quality RNA (RNA Integrity number or RIN \> 9.0) was processed using an Illumina TruSeq RNA sample prep kit following the manufacturer's instruction (Illumina, San Diego, CA, USA). After quality control procedures, individual RNA-seq libraries were pooled based on their respective sample-specific 6-bp adaptors and sequenced at 50 bp/sequence read using an Illumina HiSeq 2000sequencer as described previously.[@b21-grsb-6-2012-067] Approximately 25.7 million sequences per sample (Mean ± SD = 25,746,641 ± 7,637,237.4) were generated.

Data analysis and bioinformatics
--------------------------------

Raw sequence reads were first checked using our quality control pipeline. Nucleotides of each raw sequence read were scanned for low quality and trimmed using SolexaQA.[@b22-grsb-6-2012-067] Trimming removed \~24.9% of the raw reads; and mean length of resultant input reads were 48.96 bp (±0.46, SD). Input reads were then aligned to the bovine reference genome (UMD3.1) using TopHat.[@b23-grsb-6-2012-067] Approximately 96.68% of input reads were aligned to the bovine genome whereas 71.58% of input reads were uniquely mapped to the gene space in the bovine genome. Each SAM output file from TopHat alignment, along with the GTF file from ENSEMBL bovine genebuild v65.0, were used in the Cuffdiff program in the Cufflink package (v1.3.0) as input files[@b24-grsb-6-2012-067] to test for differential gene expression. Mapped reads were normalized based on upper-quartile normalization method. Cuffdiff models the variance in fragment counts across replicates using the negative binomial distribution as described.[@b25-grsb-6-2012-067]

Differentially expressed genes in the transcriptome identified were further analyzed using Gene Ontology (GO) analysis (<https://github.com/tanghaibao/goatools>). Enrichment of certain GO terms was determined based on Fisher's exact test. A multiple correction control (permutation to control false discovery rate, FDR) was implemented to set up the threshold to obtain the lists of significantly over-represented GO terms.

Co-regulatory gene networks were analyzed using Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNE).[@b26-grsb-6-2012-067] Raw mapped sequence reads from 32 samples, including 24 rumen epithelial samples and 8 samples from a bovine epithelial cell line were first normalized (per million mapped reads) and log2 transformed. Only 15,469 genes with mean mapped reads greater than 10.0 across all 32 samples were used for subsequent analysis. Relative expression values of these genes were used as input files to infer global regulatory networks.

Results
=======

A snapshot of the rumen epithelial transcriptome
------------------------------------------------

Collectively, a total of 20,371 genes were detected at least once in at least one of the 24 rumen epithelial samples. The number of genes expressed per sample was 17,323.63 ± 277.20 (Mean ± SD). The number of genes with mean hits ≥ 5.0 were 15,015 whereas the core transcriptome of the rumen epithelium consisted of 15,025 genes, ie, genes represented by at least one sequence hit in each of the 24 samples tested.

According to the transcript abundance classification described previously,[@b21-grsb-6-2012-067] approximately 70.78% of genes transcribed in the rumen epithelium can be classified into "very rare" with a relative abundance ≤15 molecules per cell ([Table 1](#t1-grsb-6-2012-067){ref-type="table"}), followed by "not expressed" (0 molecule per cell) at 17.24% and "rare" (16--99 molecules per cell) at 10.41%. " Moderately abundant" genes accounted for 1.32% while the abundant transcripts with ≥500 molecules per cell accounted for only 0.25% of genes detected in the transcriptome. Unlike what was observed in the bovine muscle tissue where the transcriptome was dominated by a handful of genes (Baldwin et al 2012, personal communication), the most abundant gene in the rumen epithelial transcriptome was a mitochondrial gene, cytochrome c oxidase subunit I, represented by \~6.23% of sequence reads. The 20 most abundant genes in the rumen epithelial transcriptome, which accounted for \~23.8% of sequences, included 6 genes of mitochondrial origin, such as cytochrome b, and 3 keratin genes, such as keratin, type I cytoskeletal 17 (Ensembl ID: ENSBTAG00000006806) and keratin, type II cytoskeletal 59 kDa, component IV ( ENSBTAG00000039425). This is in contrast to the bovine small intestine transcriptome,[@b21-grsb-6-2012-067] in which the 20 most abundant genes accounted for \~13.3% of sequences. Among the 20 most abundant transcripts, only 3 genes were shared in the transcriptome of both the small intestine and the rumen epithelium, including cytochrome c oxidase subunit I (ENSBTAG00000043561), elongation factor 1-alpha 1 (ENSBTAG00000014534), and a novel protein-coding gene (ENSBTAG00000034185).

Genes significantly impacted by butyrate
----------------------------------------

A total of 80 genes were found to be affected in the rumen epithelium by butyrate infusion at ≥ one time point at a stringent cutoff, FDR \< 5% ([Table 2](#t2-grsb-6-2012-067){ref-type="table"}). Compared to pre-infusion at 0h, 24 h infusion affected 15 genes, including down-regulation of solute carrier family 5 (iodide transporter), member 8 (SLC5A8), leukocyte surface antigen (CD47), lipopolysaccharide binding protein (LBP), immunoglobulin lambda-like polypeptide 1 (IGLL1), and lactoperoxidase (LPO). The maximal effect of butyrate was observed at 72 h infusion when 59 genes were influenced, including lymphocyte antigen 6D (LY6D), keratin 75 (KRT75), and tubulin beta-3 chain (TBB3). While the impact on some genes, such as a novel protein (ENSBTAG00000039035), which was strongly induced by butyrate at only the 24 h infusion sampling, was seemingly transient, transcriptional responses of butyrate on many genes were long-lasting. The ruminal butyrate concentration returned to its pre- infusion basal level 168 h after the infusion withdrawal ([Fig. 1](#f1-grsb-6-2012-067){ref-type="fig"}). However, as many as 13 genes remained significantly affected at 168 h post-infusion, compared to 0h, and these included cadherin 26 (CDH26), desmoglein 1 (DSG1), and kallikrein-related peptidase 10 (KLK10). 53 of the 80 differentially expressed genes were also significantly impacted by butyrate in the in vitro model. However, the remaining 27 genes were only significantly regulated by butyrate in the rumen epithelium, such as dual oxidase maturation factors 1 and 2 (DUOXA1 and DUOXA2) and keratin 36 and keratin 75 (KRT 36 and KRT75). Additionally, of the 80 genes affected by butyrate, a majority were down-regulated by butyrate treatment, which is consistent with the effect of butyrate observed in bovine epithelial cells in vitro (Wu et al 2012, personal communication). Eight genes up-regulated by butyrate at ≥one time point were heat shock 70 kDa protein 6 (HSPA6, 24 h), transglutaminase 2 (TGM2, 72 h and 168 h), alcohol dehydrogenase 1C (class I), gamma polypeptide (ADH1C, 72 h and post 168 h), small nucleolar RNA SNORA31 (SNORA31, 168 h), farnesyl pyrophosphate synthase (FPPS, post 124 h), keratin 36 (KRT36, post 168 h), ornithine decarboxylase (ODC, post 168 h), and peptidoglycan recognition protein 2 (PGLYRP2, post 168 h).

Gene Ontology (GO) analysis
---------------------------

GO terms significantly enriched in the rumen epithelium in response to butyrate infusion were identified using GOATOOLs. At 24 h infusion, five biological processes were significantly enriched at a Bonferroni- corrected *P* value \< 0.05 ([Table 3A](#t3-grsb-6-2012-067){ref-type="table"}), including responses to bacteria and biotic stimuli. When all 80 genes significantly impacted by butyrate at one or more time points were analyzed, biological processes such as responses to bacteria and other organisms were enriched, consistent with the 24 h observation. In contrast, cellular components related to "organelle" were significantly depleted by butyrate infusion when assessed relative to all 15,015 genes expressed in the rumen epithelium with mean mapped reads ≥5.0 ([Table 3B](#t3-grsb-6-2012-067){ref-type="table"}).

Regulatory gene networks
------------------------

Using a combined stringent cutoff of an error tolerance ɛ = 0.10 and a *P*-value threshold of mutual information (MI) at 5.0 × 10^−11^, ARACNE inferred global gene networks with 113,738 direct interactions in the butyrateepithelium interactome. Top 67 genes controlling \>5% of all direct interactions and can be considered as hubs or master regulators (Supplementary File 1). Among these genes, 46 were impacted by butyrate in in vivo and/or in vitro models. Of the 46, 7 were known transcription factors or translation regulators, including CREB binding protein (CREBBP), eukaryotic translation termination factor 1 (ETF1), hypoxia inducible factor 1, alpha (HIF1A), lysine (K)-specific demethylase 5A (KDM5A), regulatory factor X, 2 (RFX2), transcription elongation factor A (3TCEA3), and transcription termination factor, RNA polymerase II (TTF2). The master regulator with the greatest number of direct interactions (or the first neighbors) was ETF1 (ENSBTAG00000011415). The product of this gene acts as an omnipotent protein release factor (RF) and directs the termination of nascent peptide synthesis (translation) in response to termination codons. ETF1 was down-regulated by butyrate in vitro (*P* value = 3.97 × 10^−8^, FDR = 1.00 × 10^−5^). ARACNE inferred 123 direct interactions (1st neighbors) and 6,195 2nd neighbors for ETF1. Among the indirect interactions (2nd neighbors), 1052 of the 1472 genes involved were significantly impacted by butyrate, including a total of 111 transcription factors in vitro. The predominant GO terms identified as enriched among its 1st neighbors relate to the cellular component organelle (GO:0043226), including membrane-bounded organelle (GO:0043227) and intracellular organelle (GO:0043229). CREBBP (ENSBTAG00000026403) encodes a protein with intrinsic histone acetyltransferase activity, which acetylates both histone and non-histone proteins. CREBBP acts as a transcriptional coactivator of RNA polymerase II-mediated transcription and is known to play a critical role in cell growth and human diseases. This gene was significantly down-regulated by butyrate infusion and had 87 1st neighbors ([Fig. 2](#f2-grsb-6-2012-067){ref-type="fig"}). An additional 189 genes were involved in 3,327 of indirect interactions of CREBBP (2nd neighbors). Of these CREBBP 2nd neighbors, 140 were regulated by butyrate including 19 transcription factors. Not coincidently, the GO terms predominantly enriched in the direct interaction of CREBBP were related to biological processes such as histone modification (GO:0016570) and covalent chromatin modification (GO0016569), cellular components such as histone acetyltransferase complex (GO:0000123) and NuA4 histone acetyltransferase complex (GO:0035267), and molecular functions such as histone acetyltransferase activity (GO:0004402) and nucleic acid binding (GO:0003676).

Discussion
==========

Multiple effects of butyrate on local (intestinal) and systemic physiological function are presumably due to its actions as a potent regulator of gene expression.[@b4-grsb-6-2012-067]--[@b6-grsb-6-2012-067] Butyrate metabolism, both biosynthesis by gut microorganisms and utilization in the gut, is tightly regulated and thus, imbalance could play a critical role in the pathology of humans and animals. Typically, increased production of SCFA, especially butyrate, results in lower luminal pH, which, in turn, creates favorable niche for and stimulates proliferation of butyrate-producing bacteria.[@b12-grsb-6-2012-067] In modern intensive production systems used for ruminants, especially during physiologically critical stages, such as weaning and the transition or periparturient period in dairy cattle, high concentrate rations are fed which can result in abrupt increases in SCFA production. This circumstance often results in production in excess of the utilization capacity, subsequently leading to the development of ruminal acidosis, a prominent digestive disorder with a significant economical impact.[@b27-grsb-6-2012-067],[@b28-grsb-6-2012-067] Individual variation in the capacity for uptake of acetate and butyrate among animals fed the same rations can explain the degree of acidosis observed.[@b29-grsb-6-2012-067] In fact, considerable effort has focused on development of practical nutritional intervention strategies for use during transition periods to enhance rumen epithelial surface area prior to the introduction of high VFA producing rations to facilitate better absorptive capacity and mitigate negative effects of acidosis.[@b30-grsb-6-2012-067] To date, these strategies have yielded mixed results with respect to increasing papillae surface area and total absorptive capacity (Andersen, personal communication). The development of a better understanding of the regulation of both rumen epithelial growth promotion and VFA transport capacity remains a concern to the industry.[@b29-grsb-6-2012-067] In this study, we assessed the rumen epithelial transcriptome dynamics when butyrate concentration was elevated due to direct ruminal infusion with buffered butyric acid in order to assess transcriptional effects of butyrate and its potential role in regulating butyrate transport in cattle.

The majority of our knowledge on regulatory impact of butyrate on global gene expression is derived from in vitro studies and observations.[@b6-grsb-6-2012-067],[@b31-grsb-6-2012-067],[@b32-grsb-6-2012-067] However, caution in interpretation of in vitro data and application of knowledge gained in vitro to in vivo models is warranted. SCFAs, such as butyrate, are known to promote rumen development and stimulate the proliferation of rumen epithelial cells in vivo.[@b33-grsb-6-2012-067] However, butyrate inhibits the proliferation of epithelial cells of the large intestine, rumen and kidney by down- regulating genes controlling cell proliferation in vitro.[@b2-grsb-6-2012-067],[@b32-grsb-6-2012-067] Butyrate also induces apoptosis and differentiation of tumor cells.[@b34-grsb-6-2012-067],[@b35-grsb-6-2012-067] Moreover, an in vitro study of epithelial cells of different origin (rat small intestine vs. human colon) has demonstrated that the cell type affects butyrate uptake characteristics.[@b36-grsb-6-2012-067] In fact, opposite effects of butyrate are observed for many cellular processes, such as cell proliferation and division, between in vitro and in vivo models and are clearly reflected in transcriptome characteristics.[@b33-grsb-6-2012-067],[@b37-grsb-6-2012-067] A number of genes related to cell proliferation and cell cycle progress were significantly down-regulated by a 24-h 10 mM butyrate incubation of established bovine rumen epithelial cells in long-term culturing (Wu et al 2012, personal communication). In contrast, expression of these same genes in the rumen epithelium in the present data set was not altered despite a 2-fold increase from 19.5 mM to 38.5 mM in intraruminal butyrate concentration ([Fig. 1](#f1-grsb-6-2012-067){ref-type="fig"}). Interestingly, the abundance of a butyrate transporter, SLC5A8, in the rumen epithelial transcriptome was significantly reduced concomitant with intra-ruminal butyrate concentration increases. However, SLC5A8 expression at the mRNA level was significantly increased \~21 fold by butyrate exposure in vitro ([Fig. 3](#f3-grsb-6-2012-067){ref-type="fig"}). This apparent opposite effect of butyrate on the expression of its transporter is suggestive of alternative regulatory mechanisms relating to butyrate uptake control and transport by the intact rumen epithelium and cells in culture. Moreover, cellular butyrate metabolism may be different between in viv*o* and in vitro models due to changes in the rate of removal of end product as well as changes between cell-cell interactions and micro-environments present in vivo, but disrupted in vitro. To this point, epithelial metabolism of butyrate, especially the pathways leading to ketogenesis, helps to maintain a butyrate concentration gradient in vivo, which in turn facilitates butyrate uptake and affects butyrate intracellular concentrations.[@b30-grsb-6-2012-067] Rate-limiting enzymes in the ruminal ketogenic process, such as acetyl-CoA acetyl transferase (ACAT) and 3-hydroxy-3-methylglutaryl CoA synthases (HMGCS) 1 (cytoplasmic) and 2 (mitochondrial), play an important role in regulating butyrate metabolism at the substrate level. As depicted in [Table 4](#t4-grsb-6-2012-067){ref-type="table"}, key enzymes in butyrate metabolic pathways exhibited a different expression pattern between the cell line and the rumen epithelium. As expected, HMGCS2 of mitochondrial origin was significantly up-regulated by butyrate in vitro, in response to increased butyrate concentration. However, expression of HMGCS2 remained unchanged in vivo.

The biological interpretation of high-throughput expression data generated using microarrays or RNA-seq technology requires both differential expression and differential network analyses.[@b38-grsb-6-2012-067] Many transcriptional regulators exert their impact on biological functions via post-transcriptional mechanisms with subtle or no apparent changes at mRNA expression level detectable by tools for assessing differential expression alone. However, differential network analysis relies on powerful computational tools to extract accurate regulatory gene networks reflecting causal interactions underlying biological processes or phenotypes. Of several algorithms available, those based on information theory, including estimating mutual information values, such as ARACNE[@b26-grsb-6-2012-067],[@b39-grsb-6-2012-067] perform well in inferring global gene networks, especially for smaller sample sizes.[@b40-grsb-6-2012-067],[@b41-grsb-6-2012-067] ARACNE is based on the assumptions that the expression level of a given gene is a random variable and the mutual relationships between them can be derived by statistical dependences.[@b42-grsb-6-2012-067] Our results provided further support for the utility of this approach in constructing regulatory gene networks that depict phenotypes and regulation of biological processes. An example from this current study is the regulatory network controlled by FBJ murine osteosarcoma viral oncogene homolog, or c-fos (FOS), which was significantly down-regulated by butyrate in both in vitro and in vivo models. As a transcription factor, FOS dimerizes with another oncogene JUN to form the AP-1 complex, which regulates transcription of a diverse range of genes and is implicated in many biological processes including cell proliferation and differentiation as well as tumor transformation and progression. In the current data set, ARACNE inferred a network of four direct interactions (1st neighbors) for FOS and 32 indirect interactions ([Fig. 4](#f4-grsb-6-2012-067){ref-type="fig"}). All four direct interactions, cingulin (CGN), heparin-binding epidermal growth factor-like growth factor (HBEGF), intermediate filament family orphan 2 (IFFO2), and jun proto-oncogene (JUN), were up-regulated by butyrate (at both *P* \< 10^−6^ and FDR \< 10^−5^). Moreover, of 24 genes in the 2nd neighbors category, all were also regulated by butyrate, including three transcription factors, JUN, upstream transcription factor 2, c-fos interacting (USF2), and REST corepressor 1 (RCOR1). GO analysis identified GO terms significantly enriched in this network, including SMAD binding (GO:0046332 and GO:0070412), SMAD protein signal transduction (GO:0060395), and transforming growth factor (TGF)-β receptor signaling (GO:0007179). FOS binding at the TGF-β1 promoter proximal AP-1 site is required for TGF-β1 production by colon carcinoma cells.[@b43-grsb-6-2012-067] Indeed, previous studies have shown that SMAD proteins cooperate with FOS/JUN complex to mediate TGF-β-induced transcription.[@b44-grsb-6-2012-067] Thus, ARACNE correctly inferred a direct interaction between FOS and JUN ([Fig. 4](#f4-grsb-6-2012-067){ref-type="fig"}) as well as interaction between JOS and HBEGF. HBEGF plays a pivotal role in mediating the early cellular response to intestinal injury by serving as a potent cytoprotective factor.[@b45-grsb-6-2012-067] Other experimental evidence also provides a strong support of a direct interaction between FOS and HBEGF.[@b45-grsb-6-2012-067],[@b46-grsb-6-2012-067]

Tight junctions between epithelial cells regulate the permeability of molecules via para-cellular pathways as well as bacterial translocation across the gut epithelial layer, thus having the potential to strengthen intestinal barrier function and being involved in intestinal pathology.[@b47-grsb-6-2012-067] In addition to cingulin that was induced by butyrate, at least 16 other tight junction related genes were regulated by butyrate in vitro. A strong up-regulation of the major macromolecular components, such as claudins (CLDN1, CLDN3, CLDN4, CLDN7, CLDN12, and CLDN23), tight junction protein 3 (TJP3), and junctional adhesion molecules 2 and 3 (JAM2 and JAM3), by butyrate supports the contention that these genes may play an important role in maintaining and/or restoring intestinal barrier function. Indeed, evidence indicates that probiotics, such as *Lactobacillus plantarum* MB452, enhance intestinal barrier function via increasing expression of genes encoding proteins involved in tight function formation.[@b48-grsb-6-2012-067] It is known that elevated ruminal butyrate results in a profound change in the ruminal microbial composition, including a potential stimulating effect on butyrate-producing bacteria.[@b12-grsb-6-2012-067] It is foreseeable that an elevated concentration of butyrate in the lumen of the gut could play a regulatory role in the maintenance of intestinal barrier function via the expression of genes involved in tight junctions. Our future work will include experimental verification of the global regulatory gene networks inferred by computational tools.
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![Ruminal concentrations (mM) of short-chain fatty acids in response to butyrate infusion.\
**Notes:** 0 h = baseline, immediately prior to initiation of continuous infusion with butyrate. 24 h, 72 h, and 168 h = 24, 72, and 168 h after continuous infusion, respectively. Post 24 h and post 168 h = 24 h and 168 h after infusion withdrawal, respectively. Red: acetate; Blue: butyrate; Green: propionate. Error bars = standard deviation, *N* = 4.](grsb-6-2012-067f1){#f1-grsb-6-2012-067}

![A regulatory gene network controlled by CREB binding protein (CREBBP).\
**Notes:** The network was inferred using ARACNE at a combined stringent cutoff of an error tolerance ɛ = 0.10 and a *P*-value threshold of mutual information (MI) at 5.0 × 10^−11^. CREBBP had 87 direct interactions (the first neighbors) and 4139 indirect interactions (the second neighbors, not shown). The expression of the CREBBP gene, a transcription factor, at the mRNA level was significantly regulated by butyrate. The color cycle with gene symbols represented genes significantly regulated by butyrate.](grsb-6-2012-067f2){#f2-grsb-6-2012-067}

![Relative expression of a butyrate transporter, solute carrier family 5 (iodide transporter), member 8 (SLC5A8).\
**Notes:** The number denotes the relative abundance of the transcript in both the bovine epithelial cell and in the bovine rumen epithelium. CT: control, cells treated with PBS; BT: cells treated with 10 mM butyrate for 24 h in vitro. \*False discovery rate (FDR) \< 0.05; \*\*\*FDR \< 0.001.](grsb-6-2012-067f3){#f3-grsb-6-2012-067}

![A regulatory gene network controlled by FOS.\
**Notes:** The network was inferred using ARACNE at a combined stringent cutoff of an error tolerance ɛ = 0.10 and a *P*-value threshold of mutual information (MI) at 5.0 × 10^−11^. FOS had 4 direct interactions (the first neighbors) and 32 indirect interactions. The expression of all genes in this network at the mRNA level was significantly regulated by butyrate. The green/yellow color with gene symbols represents transcription factors.](grsb-6-2012-067f4){#f4-grsb-6-2012-067}

###### 

Transcript abundance in the bovine rumen epithelium.

  Transcript category   Rumen epithelium   Small intestine
  --------------------- ------------------ -----------------
  Not expressed         17.24%             15.23%
  Very rare             70.78%             68.27%
  Rare                  10.41%             14.91%
  Moderately abundant   1.32%              1.41%
  Abundant              0.25%              0.18%

###### 

Genes significantly impacted by butyrate in the rumen epithelium detected by RNA-seq technology.

  Gene_id                   Symbol     Gene name                                                   Locus                    24 h                                                        72 h                                                       168 h                                                      Post 24 h                                                  Post 168 h
  ------------------------- ---------- ----------------------------------------------------------- ------------------------ ----------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ----------------------------------------------------------
  ENSBTAG00000001100        IL22RA1    Interleukin 22 receptor, alpha 1                            2:129351697--129378160   0.57                                                        0.37[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.41                                                       0.83                                                       0.92
  ENSBTAG00000001497        MRAS       Muscle RAS oncogene homolog                                 1:131765942--131834001   0.96                                                        0.76                                                       0.86                                                       0.81                                                       0.64[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000002088                   Uncharacterized protein                                     11:46575177--46584984    0.51[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}    0.93                                                       0.97                                                       0.96                                                       1.25
  ENSBTAG00000002404        TMX2       Thioredoxin-related transmembrane protein 2                 15:82363843--82372527    0.87                                                        0.73[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.82[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.98                                                       0.95
  ENSBTAG00000003192        TBC1D16    TBC1 domain family, member 16                               19:53181378--53245548    0.70                                                        0.56[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.79                                                       0.85                                                       0.71
  ENSBTAG00000003585        CD47       CD47 molecule                                               1:53103995--53169038     0.77[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}    0.73[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.89                                                       1.06                                                       1.21
  ENSBTAG00000003948 FPPS              Farnesyl pyrophosphate synthase                             3:15356046--15374937     1.01                                                        0.85                                                       0.88                                                       1.27[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     1.46[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000004208        PLEKHG6    Pleckstrin homology domain containing, family G member 6    5:104415804--104431128   0.73                                                        0.36[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.41[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.72                                                       0.82
  ENSBTAG00000004256        ODC        Ornithine decarboxylase                                     11:87178097--87182503    0.74                                                        0.56                                                       0.65                                                       1.29                                                       2.96[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000004322        FOS        FBJ murine osteosarcoma viral oncogene homolog              10:86883738--86887169    0.80                                                        0.43[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.55                                                       0.89                                                       0.75
  ENSBTAG00000004884        SLC4A5     Solute carrier family 4, member 5                           11:10283281--10403977    0.57                                                        0.39[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.48                                                       0.58                                                       0.67
  ENSBTAG00000004971                   GRAM domain containing 1C                                   1:58963949--59063256     0.68[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}    0.68[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.82[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     1.13                                                       0.72[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000005397        CD46       Membrane cofactor protein                                   16:77483016--77522665    0.82                                                        0.74[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.85                                                       0.88                                                       0.81
  ENSBTAG00000005466        C8orf58    Chromosome 8 open reading frame 58                          8:70406943--70412090     0.74                                                        0.70[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.84                                                       0.75                                                       0.75
  ENSBTAG00000005580        SZT2       Seizure threshold 2 homolog (mouse)                         3:103160271--103201060   0.91                                                        0.79[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.95                                                       0.92                                                       0.92
  ENSBTAG00000006464                   ADP-ribosylation factor-binding protein GGA1                5:109960752--109979896   0.91                                                        0.70[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.82[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.86                                                       0.87
  ENSBTAG00000006984        CD55       CD55 molecule, decay accelerating factor for complement     16:5105576--5124229      0.84                                                        0.68[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.84                                                       0.95                                                       1.08
  ENSBTAG00000007399        LAMP2      Lysosomal-associated membrane protein 2                     X:4846777--4879916       0.88                                                        0.78[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.82                                                       0.83                                                       0.80
  ENSBTAG00000008442        NSF        N-ethylmaleimide-sensitive factor                           19:46081985--46228565    0.74                                                        0.57[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.73                                                       0.78                                                       0.82
  ENSBTAG00000008700        CRCT1      Cysteine-rich C-terminal 1                                  3:18222997--18224799     0.55                                                        0.40[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.39[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.91                                                       0.68
  ENSBTAG00000009575        C6orf170   Chromosome 6 open reading frame 170                         9:30195128--30400435     0.86                                                        0.76                                                       0.75                                                       0.68[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.69
  ENSBTAG00000009995        CPEB4      Cytoplasmic polyadenylation element binding protein 4       20:5512160--5584540      0.75                                                        0.67[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.79                                                       0.84                                                       0.75
  ENSBTAG00000010670        VSIG8      V-set and immunoglobulin domain containing 8                3:9942946--9950485       0.58                                                        0.27[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.34[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.62                                                       0.72
  ENSBTAG00000011482        SLC43A2    Solute carrier family 43, member 2                          19:23261579--23301008    0.80                                                        0.47[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.49[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.62                                                       0.82
  ENSBTAG00000011525        SLC5A8     Solute carrier family 5 (iodide transporter), member 8      5:65387536--65453818     0.32[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}        0.33[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.38                                                       0.90                                                       1.49
  ENSBTAG00000012280        PGLYRP2    Peptidoglycan recognition protein 2                         7:8702089--8707156       1.09                                                        0.64                                                       0.82                                                       2.27                                                       7.00[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000012780        LPO        Lactoperoxidase                                             19:9441748--9471498      0.37[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}    0.72                                                       0.76                                                       1.14                                                       0.72
  ENSBTAG00000013205                   Interleukin 1 receptor accessory protein                    1:77198181--77343645     0.85                                                        0.64[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.75                                                       0.87                                                       1.00
  ENSBTAG00000013507        SPRR3      Small proline-rich protein 3                                3:17796521--17798340     0.61                                                        0.46[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.66                                                       0.89                                                       1.41
  ENSBTAG00000013578                   Uncharacterized protein                                     3:32269407--32284496     0.23[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}    0.61                                                       0.62                                                       0.88                                                       0.73
  ENSBTAG00000013831        DSG1       Desmoglein 1                                                24:26089488--26133405    0.64                                                        0.26[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.21[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.35[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.34[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000013999        FAM20B     Family with sequence similarity 20, member B                16:61810680--61852109    0.82                                                        0.68[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.83                                                       0.90                                                       0.80
  ENSBTAG00000014289        ZFYVE9     Zinc finger, FYVE domain containing 9                       3:94600423--94713143     0.79                                                        0.67[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.75                                                       0.80                                                       0.79
  ENSBTAG00000014367        PRKX       Protein kinase, X-linked                                    X:138715323--138747777   0.87                                                        0.70[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.86                                                       0.88                                                       0.87
  ENSBTAG00000014945        IQSEC2     IQ motif and Sec7 domain 2                                  X:96082196--96158317     0.82                                                        0.60[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.76                                                       0.80                                                       0.83
  ENSBTAG00000014984        RPRD2      Regulation of nuclear pre-mRNA domain containing 2          3:20254978--20345588     0.93                                                        0.80                                                       0.93                                                       0.84                                                       0.72[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000015129        KLK10      Kallikrein-related peptidase 10                             18:57448224--57454197    0.58                                                        0.45[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.36[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.68                                                       0.35[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000015796        DNAJC5     DnaJ (Hsp40) homolog, subfamily C, member 5                 13:54382946--54408528    0.85                                                        0.66[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.78                                                       0.96                                                       1.05
  ENSBTAG00000015915        SBSN       Suprabasin                                                  18:46358552--46363200    0.66                                                        0.24[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.16[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.32[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.40
  ENSBTAG00000016121        KRT75      Keratin 75                                                  5:27630614--27640849     0.81                                                        0.45[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.47                                                       0.59                                                       0.77
  ENSBTAG00000016208        TGM2       Transglutaminase 2                                          13:67663137--67697607    1.40                                                        2.05[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       2.23[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.94                                                       1.62
  ENSBTAG00000016239        DUOXA2     Dual oxidase maturation factor 2                            10:65525529--65540482    0.50                                                        0.48[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.55                                                       1.11                                                       1.22
  ENSBTAG00000016242        DUOXA1     Dual oxidase maturation factor 1                            10:65525529--65540482    0.50                                                        0.48[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.55                                                       1.11                                                       1.22
  ENSBTAG00000016864        LBP        Lipopolysaccharide binding protein                          13:67874473--67910095    0.47[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}        0.54                                                       0.63                                                       0.86                                                       0.92
  ENSBTAG00000016968        CHST4      Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4   18:39665072--39671884    0.38[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}        0.39[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.55                                                       0.94                                                       0.71
  ENSBTAG00000018252        ARRDC4     Arrestin domain containing 4                                21:8924762--8939028      0.49[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}        0.46[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.41[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.96                                                       0.87
  ENSBTAG00000018937                   Heme oxygenase (decycling) 2                                25:3621446--3649596      0.88                                                        0.72[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.81[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.90                                                       0.94
  ENSBTAG00000019107        GAS7       Growth arrest-specific 7                                    19:29670743--29876650    0.96                                                        0.69[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.87                                                       0.86                                                       0.81
  ENSBTAG00000019822        TPPP3      Tubulin polymerization-promoting protein family member 3    18:35121242--35124820    1.73                                                        0.29                                                       0.20[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.69                                                       0.71
  ENSBTAG00000019876        DSC1       Desmocollin 1                                               24:26283414--26321590    1.07                                                        0.78                                                       0.66[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.63                                                       0.76
  ENSBTAG00000020261        CDH26      Cadherin 26                                                 13:57056796--57091107    0.21                                                        0.20                                                       0.16                                                       0.20                                                       0.13[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000020384        WDR47      WD repeat domain 47                                         3:34446313--34506800     0.82                                                        0.57[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.62[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.75                                                       0.75
  ENSBTAG00000023026        SERPINB2   Serpin peptidase inhibitor, clade B (ovalbumin), member 2   24:12747968--12765314    1.10                                                        0.44[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.43[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.64                                                       0.99
  ENSBTAG00000023730        TBB3       Tubulin beta-3 chain                                        18:14761259--14769914    0.79                                                        0.49[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.51                                                       0.69                                                       0.81
  ENSBTAG00000025531        PSORS1C2   Psoriasis susceptibility 1 candidate 2                      23:27793272--27794712    0.50                                                        0.49[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.63                                                       1.19                                                       0.97
  ENSBTAG00000026585                   Elongin A                                                   2:129738382--129752889   0.87                                                        0.70[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.81                                                       1.00                                                       1.01
  ENSBTAG00000027225        LAP        Lingual antimicrobial peptide                               27:5124122--5125987      0.35[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}    0.36[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.38[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.55                                                       0.76
  ENSBTAG00000030301        MAP7D1     MAP7 domain containing 1                                    3:110233981--110243621   0.70                                                        0.48[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.62                                                       0.83                                                       1.00
  ENSBTAG00000030484        KLK12      Kallikrein-related peptidase 12                             18:57461616--57465567    0.53                                                        0.47                                                       0.29[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.60                                                       0.24[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000031160        IGLL1      Immunoglobulin lambda-like polypeptide 1                    17:72826679--73152862    0.61[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}      0.80                                                       1.10                                                       1.12                                                       0.77
  ENSBTAG00000031551        PRSS53     Protease, serine, 53                                        25:27450355--27455369    0.46[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}        0.40[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.38[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.67                                                       0.76
  ENSBTAG00000033107        OSMR       Oncostatin M receptor                                       20:35521409--35588186    0.71                                                        0.56[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.69                                                       0.93                                                       1.08
  ENSBTAG00000033398        HKDC1      Hexokinase domain containing 1                              28:25752420--25791456    0.63                                                        0.31[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.30[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.48                                                       0.77
  ENSBTAG00000033669        IL17RC     Interleukin 17 receptor C                                   22:16873473--16885025    0.91                                                        0.70[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.80                                                       0.96                                                       1.16
  ENSBTAG00000034189        ADH1C      Alcohol dehydrogenase 1C (class I), gamma polypeptide       6:26656287--26672428     0.86                                                        4.57[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       3.46                                                       0.94                                                       5.55[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000034498        LY6D       Lymphocyte antigen 6D                                       14:2801382--2803020      0.56                                                        0.19[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.37                                                       0.34                                                       0.52
  ENSBTAG00000035171        SERPINB5   Serpin peptidase inhibitor, clade B (ovalbumin), member 5   24:62319471--62329373    0.89                                                        0.69                                                       0.52                                                       0.30[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.43
  ENSBTAG00000038540                   Uncharacterized protein                                     26:25060218--25073503    0.97                                                        0.66[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.72                                                       0.80                                                       0.81
  ENSBTAG00000038878        Aox4       Aldehyde oxidase 4                                          2:89699123--89771871     0.68                                                        0.46                                                       0.32[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.16[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.44
  ENSBTAG00000039035                   Uncharacterized protein                                     3:8027844--8029776       13.40[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.98                                                       1.10                                                       2.05                                                       0.85
  ENSBTAG00000040356        SPIRE2     Spire homolog 2 (Drosophila)                                18:14694451--14723123    0.78                                                        0.65[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.80                                                       0.90                                                       0.90
  ENSBTAG00000040394        PRSS27     Protease, serine 27                                         25:2126943--2133828      0.46[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}        0.50                                                       0.50                                                       0.62                                                       0.63
  ENSBTAG00000040507        ARHGEF18   Rho/Rac guanine nucleotide exchange factor (GEF) 18         7:17513880--17565624     0.74                                                        0.58[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.75                                                       0.94                                                       0.90
  ENSBTAG00000043553        GPX3       Glutathione peroxidase 3 (plasma)                           7:64286947--64295116     0.51                                                        0.49[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.52                                                       0.71                                                       0.67
  ENSBTAG00000044673        SNORA31    Small nucleolar RNA SNORA31                                 4:15035753--15183208     0.99                                                        2.17                                                       2.70[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.98                                                       1.10
  ENSBTAG00000046124        KRT36      Keratin 36                                                  19:42325913--42329903    0.91                                                        2.96                                                       1.34                                                       2.37                                                       4.41[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000046158        CFB        Complement factor B                                         23:27225269--27231292    0.61                                                        0.50[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.62                                                       1.00                                                       1.83
  ENSBTAG00000046482                   Uncharacterized protein                                     10:26113953--26114424    0.35[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}        0.34[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.52                                                       0.69                                                       0.70
  ENSBTAG00000046917        GPR22      G protein-coupled receptor 22                               4:48576431--48851596     0.83                                                        0.74[\*\*](#tfn3-grsb-6-2012-067){ref-type="table-fn"}     0.76[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}   0.92                                                       0.82[\*\*\*](#tfn4-grsb-6-2012-067){ref-type="table-fn"}
  ENSBTAG00000047345                   Uncharacterized protein                                     18:52984271--53016520    0.86                                                        0.67[\*](#tfn2-grsb-6-2012-067){ref-type="table-fn"}       0.81                                                       0.98                                                       1.05

**Notes:** Numbers denote fold changes (treated/control at 0 h, *N* = 4).

FDR \< 5%;

FDR \< 1%;

FDR \< 0.1%.

###### 

Gene Ontology (GO) terms significantly impacted in the rumen epithelium by butyrate. (**A**) At 24 h infusion. (**B**) Collectively in all time points.

  GO_id        Status   GO description                                 Ratio     *P*\_unadjusted   *P*\_bonferroni   FDR
  ------------ -------- ---------------------------------------------- --------- ----------------- ----------------- --------
  (**A**)                                                                                                            
  GO:0009617   E        Response to bacterium                          4/67      4.85E-07          1.72E-04          0.0000
  GO:0051707   E        Response to other organism                     4/137     8.52E-06          3.02E-03          0.0100
  GO:0042742   E        Defense response to bacterium                  3/56      2.19E-05          7.77E-03          0.0270
  GO:0051704   E        Multi-organism process                         4/208     4.41E-05          1.56E-02          0.0390
  GO:0009607   E        Response to biotic stimulus                    4/219     5.39E-05          1.91E-02          0.0430
  GO:0050729   E        Positive regulation of inflammatory response   2/25      0.000278          9.85E-02          0.1220
  (**B**)                                                                                                            
  GO:0043231   P        Intracellular membrane-bounded organelle       8/4872    3.47E-06          0.0029            0.0030
  GO:0043227   P        Membrane-bounded organelle                     9/4877    1.89E-05          0.0158            0.0120
  GO:0043229   P        Intracellular organelle                        12/5577   2.07E-05          0.0174            0.0130
  GO:0009617   E        Response to bacterium                          5/68      3.03E-05          0.0254            0.0550
  GO:0043226   P        Organelle                                      13/5583   6.13E-05          0.0514            0.0740
  GO:0004252   E        Serine-type endopeptidase activity             5/81      7.06E-05          0.0593            0.0780
  GO:0051707   E        Response to other organism                     6/140     1.01E-04          0.0845            0.1540

**Notes:**

Ratio = the number of significantly regulated genes that can be assigned to this GO term/all genes assigned to this GO term \[among 15,015 genes expressed in the rumen epithelium with a mean hit count ≥ 5.0\]. Under the status, "E" (enriched) = GO term is significantly higher in the study group than those in the population while "P" (depleted) = GO terms significantly lower in the study group than in the population. The number of permutation = 1000.

###### 

Expression levels of key enzymes involved in butyrate metabolism in the rumen epithelium detected by RNA-seq technology.

  Gene_id              Annotation                                  Symbol   In vitro                                                   24 h   72 h   168 h   Post 24 h   Post 168 h
  -------------------- ------------------------------------------- -------- ---------------------------------------------------------- ------ ------ ------- ----------- ------------
  ENSBTAG00000002827   Acetyl-CoA acetyltransferase 2              ACAT2    0.32[\*\*\*](#tfn9-grsb-6-2012-067){ref-type="table-fn"}   0.95   0.76   0.76    1.11        1.24
  ENSBTAG00000011839   3-hydroxy-3-methylglutaryl-CoA synthase 1   HMGCS1   0.63[\*\*\*](#tfn9-grsb-6-2012-067){ref-type="table-fn"}   0.91   0.67   0.67    1.49        1.69
  ENSBTAG00000003898   3-hydroxy-3-methylglutaryl-CoA synthase 2   HMGCS2   1.30[\*](#tfn8-grsb-6-2012-067){ref-type="table-fn"}       0.95   0.86   0.94    0.84        0.91
  ENSBTAG00000015107   Monocarboxylate transporter 1               MCT1     0.52[\*\*\*](#tfn9-grsb-6-2012-067){ref-type="table-fn"}   0.98   0.84   0.95    0.90        0.84

**Notes:** The number denotes fold changes (treated/control).

FDR \< 0.05;

FDR \< 0.001.
